ES search | Evernorth

Sort by

Close search filters

Changing filters will change the listed Success Criteria and Techniques

Category

Search results (29)

Article

Gene therapies: Million-dollar miracles

August 31, 2023

Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...

Article

Uncovering behind-the-scenes challenges in bringing gene therapies to market

June 07, 2022

Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.

Article

The future of gene therapy

Recent research suggests that the number of gene therapies on the market is likely to increase to over 60 by 2030. As rapid advancements in the field continue, here is what plan sponsors can expect to...

Mary Dorholt, PharmD, October 20, 23

Article

Gene therapies 101

We answer our clients’ burning questions about gene therapies, including how they work, whether or not they’re safe, and if we’ll see more in the future.

Mary Dorholt, PharmD, February 12, 20

Article

Understanding gene modification and cellular therapies

Gene modification and cellular therapies are unique, potentially curative treatments that leverage gene-altering technology

Mary Dorholt, PharmD, June 02, 21

Article

What to look for in the upcoming gene therapy pipeline

As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.

Mary Dorholt, PharmD, April 20, 23

Article

How to have a data-driven discussion on gene and cellular therapies

As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.

Mary Dorholt, PharmD, October 28, 21

Article

Gene therapies, today and tomorrow

April 12, 2024

By supporting and encouraging evidence-based access to gene therapy, payers and other segments of U.S. society will be positioned to benefit from future advancements and biopharmaceutical breakthrough...

Article

As more gene therapies come to market, payers need expanded options to protect their plans

August 28, 2024

Article

Addressing the growing impact of gene therapies on employer plans

August 18, 2025

As the gene therapy market evolves, it’s more important than ever for employers to put the right gene therapy management program in place.